Develops immunotherapies for cancer treatment
Replimune has raised €27M across 1 funding round from 2 investors, most recently a Series A round in Sep 2015. Based in Oxford, UK; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Series A | €27M |
| Atlas Venture,Forbion Capital Partners |
| View deal → |
